Language attrition · children with Down syndrome aged between birth and six years
1 finding from 1 review
Expressive language (number of words; standard scores; MLUw; NDW; IPSyn; frequency of unique targets; % target talk) · children with Down syndrome aged between birth and six years
1 finding from 1 review
Receptive language (total language; standard scores) · children with Down syndrome aged between birth and six years
1 finding from 1 review
Percentage of participants not requiring postoperative opioids over initial 72 hours · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Percentage of participants not requiring postoperative opioids over initial 72 hours · aged 18 years and older undergoing elective surgery at any surgical site
1 finding from 1 review
Intervention not reported
Percentage of participants not requiring postoperative opioids over initial 72 hours · adults aged ≥ 18 years undergoing elective surgery at any surgical site
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
(1 to 5 years) · Patients with gastro‐oesophageal reflux disease (GORD) in adults
1 finding from 1 review
(5 years or more) · Patients with gastro‐oesophageal reflux disease (GORD) in adults
It is very uncertain whether laparoscopic fundoplication changes (5 years or more) compared with medical management (very low certainty).
1 finding from 1 review
Overall survival (3 years) · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
It is very uncertain whether combination chemotherapy changes overall survival (3 years) compared with single‐agent chemotherapy (very low certainty).
1 finding from 1 review
Disease-free survival · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
It is very uncertain whether combination chemotherapy changes disease‐free survival (3 years) compared with single‐agent chemotherapy (very low certainty).
1 finding from 1 review
Neurosensory disability · women during pregnancy
Universal screening showed no clear difference in neurosensory disability (any of cerebral palsy, blindness, deafness,… compared with no screening (moderate certainty).
1 finding from 1 review
Neurosensory disability · women during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean weight‐for‐age z‐score · children aged 6 to 23 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean weight‐for‐age z‐score · children aged 6 to 23 months
1 finding from 1 review
Intervention not reported
Age of onset of independent walking (months) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay
1 finding from 1 review
Intervention not reported
Age of onset of walking with assistance (days in study) · children under six years with cerebral palsy or Down syndrome or at risk of neuromotor delay
1 finding from 1 review
Split renal function (SRF; · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
Upper urinary tract dilatation ( · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
UPJO‐associated clinical symptoms · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Adverse events ‐ infection at 3 years · primary membranous nephropathy in adults with nephrotic syndrome
It is very uncertain whether oral alkylating agents ± steroids changes adverse events ‐ infection at 3 years compared with placebo/no treatment/steroids (very low certainty).
1 finding from 1 review